A new expert consensus decision pathway from the American College of Cardiology (ACC) provides guidance around the management of myocarditis from diagnosis to follow-up. In light of recent advances in ...
The FDA updated warnings for Pfizer and Moderna COVID-19 vaccines to includes risks of myocarditis and pericarditis. A follow-up study showed some individuals who developed myocarditis after ...
Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart inflammation is a window into how powerful immune technologies sometimes misfire in ...
Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...
Madrid, Spain – 29 August: New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025. This is the first time ...
Please provide your email address to receive an email when new articles are posted on . T-cell receptors in the hearts of patients with immunotherapy-induced myocarditis differed from those in their ...
Myocarditis is a rare yet serious condition known for the inflammation of the heart muscle, also known as the myocardium. In severe cases of myocarditis, the heart muscle becomes extremely weak and ...
Top federal health officials actively took steps to “delay warning the public” for months in 2021 about the potential risks of heart-related complications from receiving mRNA COVID-19 vaccines, a ...